ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,949Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 1942

$528K Total Retail Price of All Prescriptions

Rank: 72 out of 1942

543 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,575 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
OMEPRAZOLE 460 344 1 4
LISINOPRIL 412 357 2 2
SIMVASTATIN 401 332 3 1
FUROSEMIDE 357 321 4 5
HYDROCODONE-ACETAMINOPHEN 314 201 S3 5 12
ATENOLOL 293 223 6 7
METOPROLOL TARTRATE 284 260 7 9
LEVOTHYROXINE SODIUM 277 214 8 3
HYDROCHLOROTHIAZIDE 240 194 9 8
AMLODIPINE BESYLATE 235 211 10 6
WARFARIN SODIUM 190 189 11 11
POTASSIUM CHLORIDE 184 178 12 17
CITALOPRAM HBR 167 107 13 15
ZOLPIDEM TARTRATE 158 98 14 25
GABAPENTIN 148 108 15 16
METOPROLOL SUCCINATE 130 118 16 13
METFORMIN HCL 122 121 17 10
TRAZODONE HCL 122 57 17 24
FLUOXETINE HCL 119 50 19 45
TRAMADOL HCL 105 71 20 19
LANTUS 104 66 21 49
ALENDRONATE SODIUM 103 99 22 21
SERTRALINE HCL 101 94 23 20
CYCLOBENZAPRINE HCL 91 42 R 24 73
AZITHROMYCIN 88 72 25 43
ALLOPURINOL 87 87 26 26
ADVAIR DISKUS 86 60 27 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 74 27 22
PREDNISONE 83 74 29 27
TAMSULOSIN HCL 76 66 30 29
POLYETHYLENE GLYCOL 3350 73 60 31 28
ATORVASTATIN CALCIUM 69 52 32 14
CELEBREX 67 46 33 93
DIOVAN 65 53 34 44
PANTOPRAZOLE SODIUM 64 52 35 48
SPIRIVA 58 31 36 57
PROPRANOLOL HCL 57 29 37 101
DIGOXIN 53 53 38 40
PROAIR HFA 53 34 38 41
DONEPEZIL HCL 52 52 40 30
CARVEDILOL 51 41 41 39
LEVEMIR FLEXPEN 51 38 41 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.